Kaiser Clemens G, Baltzer Pascal, Kaiser Anna K, Krammer Julia, Uder Michael, Kaiser Werner A, Dietzel Matthias
Institute of Clinical Radiology and Nuclear Medicine, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Germany.
Department of Biomedical Imaging and Image-guided therapy, Medical University Vienna, Austria.
Eur J Radiol Open. 2016 Aug 28;3:236-8. doi: 10.1016/j.ejro.2016.08.004. eCollection 2016.
To examine "constant lesion sharpness" as a morphological diagnostic sign in the differential diagnosis between benign and malignant lesions.
This prospective study had institutional review board approval and was HIPAA compliant. In total 1014 consecutive patients were examined (mean age 55 years ± 13 years) and evaluated in our University hospital towards the morphological shape of the lesion borders. The "Constant sharpness Sign" was defined as a lesion remaining continuously sharp for the duration of the dynamic scan. Inclusion criteria were unclear findings (e.g. BIRADS III/IV), Preoperative staging (BRIDAS IV/V), and referred patients from local clinic of gynecology. Exclusion criteria were MRM-examination ≤1 year before, status after surgery and/or biopsy, chemotherapy and/or radiation therapy. Reference Standard was histological verification. Images were diagnosed by two experienced radiologists in consensus, blinded to the standard of reference.
1014 patients with 1084 lesions (436 benign, 648 malignant lesions) were included into the study. 41.5% of benign lesions and 6.8% (181/436) of malignant lesions displayed a constant sharpness as an accompanying morphological sign (P < 0.001). This resulted in a sensitivity of 41.5%, specificity of 93.2%, a positive likelihood ratio of 6.1%, a negative likelihood ratio of 0.63 and an odd's ratio of 9,7%.
The constant sharpness sign seems to be an accurate predictor of benign breast lesions, which may help to increase the accuracy of MRM as a morphological sign.
探讨“恒定病变清晰度”作为良性与恶性病变鉴别诊断中的一种形态学诊断征象。
本前瞻性研究获得机构审查委员会批准且符合健康保险流通与责任法案(HIPAA)。共有1014例连续患者接受检查(平均年龄55岁±13岁),并在我们的大学医院对病变边界的形态进行评估。“恒定清晰度征象”定义为在动态扫描期间病变边界持续保持清晰。纳入标准为检查结果不明确(如乳腺影像报告和数据系统[BIRADS]III/IV级)、术前分期(BIRADS IV/V级)以及来自当地妇科诊所的转诊患者。排除标准为术前乳房切除术(MRM)检查在1年以内、手术和/或活检后的状态、化疗和/或放疗。参考标准为组织学验证。由两名经验丰富的放射科医生在不知参考标准的情况下达成共识进行图像诊断。
1014例患者共1084个病变(436个良性病变,648个恶性病变)纳入研究。41.5%的良性病变和6.8%(181/436)的恶性病变表现出恒定清晰度作为伴随的形态学征象(P<0.001)。这导致敏感度为41.5%,特异度为93.2%,阳性似然比为6.1%,阴性似然比为0.63,比值比为9.7%。
恒定清晰度征象似乎是乳腺良性病变的准确预测指标,这可能有助于提高MRM作为一种形态学征象的准确性。